228 related articles for article (PubMed ID: 17543080)
1. Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia.
Beschorner R; Simon P; Schauer N; Mittelbronn M; Schluesener HJ; Trautmann K; Dietz K; Meyermann R
Histopathology; 2007 Jun; 50(7):897-910. PubMed ID: 17543080
[TBL] [Abstract][Full Text] [Related]
2. Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury.
Beschorner R; Dietz K; Schauer N; Mittelbronn M; Schluesener HJ; Trautmann K; Meyermann R; Simon P
Histol Histopathol; 2007 May; 22(5):515-26. PubMed ID: 17330806
[TBL] [Abstract][Full Text] [Related]
3. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of glutamate transporters in subcortical white matter after transient focal cerebral ischemia.
Arranz AM; Gottlieb M; Pérez-Cerdá F; Matute C
Neurobiol Dis; 2010 Jan; 37(1):156-65. PubMed ID: 19804828
[TBL] [Abstract][Full Text] [Related]
5. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
Apricò K; Beart PM; Crawford D; O'Shea RD
J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
[TBL] [Abstract][Full Text] [Related]
6. Glutamate transporter expression and function in human glial progenitors.
Maragakis NJ; Dietrich J; Wong V; Xue H; Mayer-Proschel M; Rao MS; Rothstein JD
Glia; 2004 Jan; 45(2):133-43. PubMed ID: 14730707
[TBL] [Abstract][Full Text] [Related]
7. Chronic brain ischemia induces the expression of glial glutamate transporter EAAT2 in subcortical white matter.
Yatomi Y; Tanaka R; Shimura H; Miyamoto N; Yamashiro K; Takanashi M; Urabe T; Hattori N
Neuroscience; 2013 Aug; 244():113-21. PubMed ID: 23602887
[TBL] [Abstract][Full Text] [Related]
8. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
[TBL] [Abstract][Full Text] [Related]
9. Expression of PACAP and glutamate transporter proteins in satellite oligodendrocytes of the human CNS.
van Landeghem FK; Weiss T; von Deimling A
Regul Pept; 2007 Jul; 142(1-2):52-9. PubMed ID: 17346813
[TBL] [Abstract][Full Text] [Related]
10. Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electron microscopic study.
Roberts RC; Roche JK; McCullumsmith RE
Neuroscience; 2014 Sep; 277():522-40. PubMed ID: 25064059
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis.
Xing HQ; Hayakawa H; Gelpi E; Kubota R; Budka H; Izumo S
J Neuropathol Exp Neurol; 2009 Feb; 68(2):199-209. PubMed ID: 19151621
[TBL] [Abstract][Full Text] [Related]
12. Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly.
Furuta A; Takashima S; Yokoo H; Rothstein JD; Wada K; Iwaki T
Brain Res Dev Brain Res; 2005 Mar; 155(2):155-64. PubMed ID: 15804404
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
Jensen AA; Bräuner-Osborne H
Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
[TBL] [Abstract][Full Text] [Related]
14. Increased expression and function of glutamate transporters in multiple sclerosis.
Vallejo-Illarramendi A; Domercq M; Pérez-Cerdá F; Ravid R; Matute C
Neurobiol Dis; 2006 Jan; 21(1):154-64. PubMed ID: 16061389
[TBL] [Abstract][Full Text] [Related]
15. Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: Evidence for delayed up-regulation and redistribution of GLT-1.
O'Shea RD; Lau CL; Farso MC; Diwakarla S; Zagami CJ; Svendsen BB; Feeney SJ; Callaway JK; Jones NM; Pow DV; Danbolt NC; Jarrott B; Beart PM
Neurochem Int; 2006; 48(6-7):604-10. PubMed ID: 16530295
[TBL] [Abstract][Full Text] [Related]
16. Localization and expression of the glutamate transporter, excitatory amino acid transporter 4, within astrocytes of the rat retina.
Ward MM; Jobling AI; Puthussery T; Foster LE; Fletcher EL
Cell Tissue Res; 2004 Mar; 315(3):305-10. PubMed ID: 14727177
[TBL] [Abstract][Full Text] [Related]
17. Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells.
Sandhu JK; Sikorska M; Walker PR
J Neurosci Res; 2002 Jun; 68(5):604-14. PubMed ID: 12111850
[TBL] [Abstract][Full Text] [Related]
18. Glutamate transporter GLAST/EAAT1 directs cell surface expression of FXYD2/gamma subunit of Na, K-ATPase in human fetal astrocytes.
Gegelashvili M; Rodriguez-Kern A; Sung L; Shimamoto K; Gegelashvili G
Neurochem Int; 2007 Jun; 50(7-8):916-20. PubMed ID: 17316900
[TBL] [Abstract][Full Text] [Related]
19. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis.
Zagami CJ; Beart PM; Wallis N; Nagley P; O'Shea RD
Glia; 2009 Jan; 57(2):119-35. PubMed ID: 18661557
[TBL] [Abstract][Full Text] [Related]
20. Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin.
Sheean RK; Lau CL; Shin YS; O'Shea RD; Beart PM
Neuroscience; 2013 Dec; 254():335-46. PubMed ID: 24095695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
